HORAN Wealth’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding HRTX
HORAN Wealth's HRTX Position: Q3 2026 in Review
HORAN Wealth held its Heron Therapeutics (HRTX) position steady in Q3 2026 at 41,590 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #350.
HORAN Wealth first reported a position in HRTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $54.1K in Q1 2026. 135 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.
- HORAN Wealth held 41,590 shares of Heron Therapeutics worth $13K as of Q3 2026.
- HORAN Wealth left its Heron Therapeutics share count unchanged in Q3 2026.
- Heron Therapeutics made up ﹤0.01% of HORAN Wealth's portfolio in Q3 2026, its #350 holding.
- HORAN Wealth first reported a position in Heron Therapeutics in Q1 2026 and has held it in 3 quarters since.
- HORAN Wealth's Heron Therapeutics position peaked at $54.1K in Q1 2026.
- 135 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.
Based on HORAN Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.